JIA-HORNG KAODING-SHINN CHEN2021-09-042021-09-0420020020-7136https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037137875&doi=10.1002%2fijc.1608&partnerID=40&md5=4367198eaadba83675243f9a5518f40ahttps://scholars.lib.ntu.edu.tw/handle/123456789/582256[SDGs]SDG3aflatoxin; curcumin; hepatitis B vaccine; hepatitis vaccine; recombinant alpha interferon; ribavirin; cancer incidence; cancer prevention; disease association; hepatitis B; Hepatitis B virus; hepatitis C; Hepatitis C virus; Hepatitis delta virus; human; liver cell carcinoma; multiple sclerosis; primary prevention; priority journal; secondary prevention; short survey; Carcinoma, Hepatocellular; Female; Hepacivirus; Hepatitis; Hepatitis Delta Virus; Hepatitis Viruses; Humans; Male; Prognosis; Risk Factors; Sex Factors; Vaccinesshort survey10.1002/ijc.1608117742752-s2.0-0037137875